Testing Semaglutide for Addiction Grigsons trial is one of several underway that directly test whether GLP-1 agonists are as effective for addiction in humans as they are in animals
Summary Keywords finerenone, diabetes mellitus, diabetic kidney disease (DKD), chronic kidney disease (CKD), mineralocorticoid receptor antagonists (MRA) Citation Alhomoud IS, Albekery MA, Alqadi R, Alqumia A, Khan RA, Al Sahlawi M and Al Mulhim MY (2025) Finerenone in diabetic kidney disease: a new frontier for slowing disease progression
Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control
Epithalon and Epitalon are two spellings for the same peptide
Mounjaro is primarily used as a treatment for people with type 2 diabetes, in combination with dietary changes and exercise
When more affordable options enter the market, the whole system responds